Anti-IL-6Ra / CD126 Reference Antibody (levilimab)
- Product Code: 140257
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in the treatment of autoimmune and inflammatory diseases, particularly rheumatoid arthritis. It targets the interleukin-6 receptor, blocking IL-6 signaling, which plays a key role in driving inflammation, joint damage, and systemic symptoms. By inhibiting this pathway, it helps reduce disease activity, slow progression of joint destruction, and improve physical function in patients. Also investigated for use in other conditions involving dysregulated IL-6 activity, such as cytokine release syndrome and certain chronic inflammatory disorders.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-IL-6Ra / CD126 Reference Antibody (levilimab)
Used in the treatment of autoimmune and inflammatory diseases, particularly rheumatoid arthritis. It targets the interleukin-6 receptor, blocking IL-6 signaling, which plays a key role in driving inflammation, joint damage, and systemic symptoms. By inhibiting this pathway, it helps reduce disease activity, slow progression of joint destruction, and improve physical function in patients. Also investigated for use in other conditions involving dysregulated IL-6 activity, such as cytokine release syndrome and certain chronic inflammatory disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :